On World Pancreatic Cancer Day, a pancreatic cancer patient, oncologist and advocate are renewing the call for a life-sustaining drug called Onivyde to be made available in Canada. As Elizabeth McSheffrey reports, the treatment was approved by Health Canada, but negotiations to distribute it across the country ended in 2019.
Canada
Pancreatic cancer survivor, advocates renew call for life-sustaining drug not available in Canada
More Videos
You are viewing an Accelerated Mobile Webpage.
View Original Article